Investigator-initiated studies still need versions, signatures and a snapshot before a number is quoted. ValidTrials can hold those without requiring a separate commercial CTMS, EDC and statistics stack. The team remains responsible for the science.
A draft starting point for the design, which the team must edit.
The eCRF matches the protocol they approved.
Methods that exist in the product, on a frozen snapshot.
Cohorts and sensitivity numbers, labeled as the analyst declared them.
The audience’s work is still the protocol, not a tour.
Turn on only what the study needs.
Scores and drafts do not approve anything.
A demonstration should use synthetic data.
It is in the product where the linked page says what the code does. Commercial packaging is a separate conversation.
We can show records and tests. We do not sign your validation for you.
Available with limitations means the described software behavior exists. A professional service is work a person does under a separate scope. Nothing here is a certification.
The conversation is about your study design and what the software can and cannot do today.
Clinical trial management for drugs, devices, and diagnostics. EU and US regulatory packages from one record. CAREPOI CRO, registered with EOF 16 November 2026.
© 2026 CAREPOI · ValidTrials · Helsinki, EU